ESCV PRE-CONFERENCE WORKSHOP:
Out of a Pandemic: Lessons Learned for Better Future Viral Diagnostics

For further details regarding the programme and registering for the pre-conference workshop, please click HERE.

SESSION 1: Neurological Infections

Chairs: Elisabeth Puchhammer, Austria & Svein Arne Nordbø, Norway

Keynote Lecture:
An update on Global Eradication of Polio
Aidan O’Leary, Switzerland

Offered Talks: 
OP-001 Host genetic factors determining antiviral NK cell response pathways associated with the development of herpes simplex type 1 encephalitis
Marianne Graninger, Austria

OP-002 Rift valley fever virus infects the sensory nervous system of zebrafish larvae in a JAK/STAT-dependent manner
Joana Rocha Pereira, Belgium

OP-003 Catastrophic bilateral sudden sensorineural hearing loss following COVID-19
Michael James Edwards, UK

SESSION 2:  Emerging and Re-emerging Viral Diseases

Chairs: Marcus Panning, Germany & Heli Harvala, UK

Keynote Lecture:
Arboviruses in Northern Europe: Tick-borne encephalitis & Sindbis viruses - more to come?
Olli Vapalahti, Finland

Offered Talks:
OP-004 Virological and immunological drivers of dengue epidemiology and physiopathology in an endemic-epidemic setting
Catherine Inizan, New Caledonia

OP-005 Dengue serotype and co-infection association with dengue severity during 2021 in Jodhpur, Rajasthan, India
Ravisekhar Gadepalli, India

OP-006 Metagenomics virome analysis of {Culex} spp. in northern Greece
Katerina Tsioka, Greece

SESSION 3
Chairs: Mariet Feltkamp, Netherlands & Paul Klapper, UK

OPENING KEYNOTE:
Discovery of Prions
Stanley Prusiner, USA

Keynote Lecture:
vCJD in the UK
Richard Knight, UK

TWiV with Vincent Racaniello
Lessons Learnt from vCJD in the UK

Vincent Racaniello, USA with Richard Knight, UK

WELCOME RECEPTION
Location: Exhibition Area "Exchange Hall"

Industry Symposium 1
Please check the symposium details from the Industry Symposia section

SESSION 4: SARS-CoV-2

Chairs: Catherine Moore, UK & Susannah Froude,UK

Keynote Lecture:
Origins of SARS
Edward Holmes, Australia

Offered Talks:
OP-007 Characterization of SARS-CoV-2 epidemic and transmission dynamics in children over the four COVID-19 waves
Rossana Scutari, Italy

OP-008 The diagnostic potential of activated CD8+ T-cells during acute COVID-19
Alexandra Vujkovic, Belgium

OP-009 Transplacental transmission of anti-SARS-CoV-2 neutralizing antibodies in comparison to other micro-organisms (CompaCoV)
Diane Brebant, France

OP-010 Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
Hebah Atif Alkhatib, Qatar

SESSION 5: Vaccines/Vaccinology

Chairs: Javier Buesa, Spain & Pamela Vallely, UK

Keynote Lecture:
Progress with vaccines for HCV
Amit Kapoor, USA

Offered Talks: 
OP-012 Measles epidemiology and susceptibility (MEAS): a community-based sero-surveillance study among children and adolescents in India
Joseph L Mathew, India

OP-013 Spray-freeze-dried mixed MS2-L2 VLPs: a thermostable candidate HPV vaccine that is applicable in low and middle-income countries
Ebenezer Tumban, USA

OP-014 Two-component Vaccine Consisting of Virus-Like Particles Displaying Hepatitis C Virus Envelope Protein 2 Oligomers
Jannick Prentoe, Denmark

OP-015 Sex and age as determinants of antibody kinetics elicited by BNT162b2 (Pfizer-BioNTech) vaccine against SARS-CoV-2
Mateo Chvatal Medina, Colombia

 Hall: Exchange Room 11
TWiV with Vincent Racaniello

Vincent Racaniello, USA with Emma Thomson, UK 

13:00 - 13:45 | Exchange Room 10

ESCV Network on NGS (ENNGS): Past, Current, and Future Activities

Organised by: Xavier Lopez-Labrador, Spain & Jutte de Vries, Netherlands

SESSION 6: Respiratory Viruses

Chairs: Kate Templeton, UK & Joel Paul, UK

Keynote Lecture:
Avian Influenza
Ian Brown, UK

 Offered Talks:
OP-017 Used nose blowing disposable tissues: a useful support to monitor respiratory viral infections both individually or in communities
Vincent Thibault, France

OP-018 Impact of detection of respiratory pathogens by a rapid multiplex PCR assay on the management of Community-Acquired Pneumonia for children at the Paediatric emergency department.
A randomized controlled trial, the OPTIPAC Study
Sylvie Pillet, France

OP-019 Nasopharyngeal excretion dynamics of SARS-CoV-2 in unvaccinated asymptomatic and mildly symptomatic patients
Carlos Davina Nunez, Spain

OP-020 Paper-based sensors for SARS-CoV-2 detection for early warning of pandemic
Zhugen Yang, UK

SESSION 7: NGS and Virus Discovery

Chairs: Peter Coyle, Qatar & Esther Babady Otete, USA

Prize as Keynote Lecture:
Next-generation sequencing, its impact on diagnostics and pandemic preparedness, 
Nicole Fischer, Germany
“Lecture to be followed by presentation of the Biomeriéux Award to Nicole Fisher, Germany” 

Offered Talks:
OP-022 Longitudinal monitoring of DNA viral loads in transplant patients using quantitative metagenomic next-generation sequencing 
Anne Russcher, Netherlands

OP-023 The donor lung is a major contributor to human cytomegalovirus strain diversity and dynamics after transplantation
Büsra Külekci, Austria

OP-024 Detection of cardiotropic viruses in endomyocardial biopsies of patients with unexplained heart failure via targeted next generation sequencing
Dominik Harms, Germany

OP-025 Metagenomic sequencing with spiked primer enrichment (MSSPE) for genotype-independent Hepatitis C virus (HCV) whole-genome analysis and antiviral resistance testing
Xavier López Labrador, Spain

OP-026 Genotyping and variant calling of human adenoviruses by tiled amplicon sequencing
Anna Matilde Toftemo, Norway

SESSION 8: Viral Hepatitis

Chairs: William Irving, UK & Paul Klapper, UK

Keynote Lecture:
New developments in the field of hepatitis E
Patrick Behrendt, Germany

Offered Talks: 
OP-027 Infection and immunity of rat hepatitis E virus: an emerging human pathogen
Sheetal Trivedi, USA

OP-028 Microarray analysis of virus-specific IgM and IgG antibodies significantly improves the serological diagnosis of Hepatitis E Virus infection
David Niklas Springer, Austria

OP-029 Host Genetic Variants Associated with Hepatitis E Virus: A Genome-Wide Association Study in Qatar
Maria K Smatti, Qatar

OP-030 Prevalence of musculoskeletal manifestations among patients with hepatitis C virus infection
Ezat Ghassan Albakri, Syria

SESSION 9: Immune Response to Infection

Chairs: George Sourvinos, Greece & Paulo Paixao, Portugal

Keynote Lecture:
Measuring and generating protective antibody responses
Rupert Beale, UK

Offered Talks: 
OP-031 Torquetenovirus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients
Morgane Solis, France

OP-032 Elevated levels of CXCL16 in severe COVID-19 patients: effects on mortality
Sandra P Smieszek, USA

OP-033 Role of the Chromosome 19 microRNA Cluster During Viral Congenital Infections
Yamileth Chin, France

OP-034 Absence of rapid T cell control corresponds with delayed viral clearance in hospitalised COVID-19 patients
Jutte J.C. de Vries, Netherlands

OP-035 Pichinde virus infection of mice and guinea pigs as comparative animal models for human Lassa fever: Immunity, immune evasion, and disease pathogenesis
Hinh Ly, USA

SESSION 10: Late Breakers

Chairs: Bert Niesters, Netherlands & George Sourvinos, Greece

Prize Lecture as Keynote:
Genomics and Microevolution of Emerging Viral Threats: insights from SARS-CoV-2 and Monkeypox, Vitor Borges, Portugal
“Lecture to be followed by presentation of the Heine-Medin Medal to Vitor Borges, Portugal”

Offered Talks: 
OP-036 Extensive surface contamination and in-vitro infectivity of surfaces in hospital rooms occupied by patients infected with monkeypox
— Germany, June 2022
Susanne Pfefferle, Germany

OP-037 High prevalence of cutavirus in parapsoriasis patients
Ushanandini Mohanraj, Finland

OP-039 Role of Long Non-Coding RNAs (lncRNAs) in HIV Latency
Ran Taube, Israel

OP-040 Severe Influenza during the 2020-21 and 2021-22 SARS-CoV-2 pandemic seasons. Re-appearance of severe H3N2 cases in 2022
Beatriz Mengual-Chulià, Spain

SESSION 11: Clinical Cases

Chairs: Heli Harvala, UK & William Irving, UK

Prize Lecture as Keynote:
Non-polio enterovirus (EV) and parechovirus-A (PeV-A) infections: a European perspective
Laura Bubba, Italy
“Lecture to be followed by presentation of the Abbott Award to Laura Bubba, Italy”

Offered Talks: 

OP-041 Congenital Cytomegalovirus Infection Among Twins: Lessons Learnt from Two Cases and Implications for Screening
Berkin Hack, UK

OP-042 Two investigations into severe non A-E hepatitis in young children in the UK
Emma Thomson, UK

OP-043 Suspected Hantavirus in Africa: nephrotic syndrome in a traveller returning from Democratic Republic of Congo
Athanasios Mamarel, UK

OP-044 Orf’ally Swollen
Helen Callaby, UK

CONFERENCE NETWORKING DINNER
(Ticketed event - tickets can be purchased through the registration form)
Location: Manchester Central, Charter Suite

SESSION 12: Antivirals
Chairs: Maria São José Alexandre, Portugal & Shazaad Ahmad,UK

Prize Lecture as Keynote:
New tools for clinical virologist in the future?
Johan Neyts, Belgium

 “Lecture to be followed by presentation of the Gardner Award to Johan Neyts, Belgium”

Offered Talks:
OP-046 Establishing a transmission and gut-immune model system to study the impact of therapeutic intervention on norovirus infection
Jana Van Dycke, Belgium

OP-047 Surveillance of herpes simplex virus and varicella-zoster virus resistance to antivirals over a 14-year period
David Boutolleau, France

OP-048 The effect of introducing Letermovir as prophylaxis for haematopoetic stem cell transplants on morbidity and mortality in Birmingham, UK
Andrew Bosworth, UK

SESSION 13: Panel discussion – Is less more?

Mass testing – Was it a necessary and cost effective service in the management of the Covid 19 pandemic?

Christopher Smith, UK, The Naked Virologist
with
Malur Sudhanva, UK & Rachel Jones, UK

CLOSING REMARKS & HANDOVER FOR ESCV 2023